Prognostic Nutritional Index and Neutrophil/Lymphocyte Ratio Can Serve as Independent Predictors of the Prognosis of Hepatocellular Carcinoma Patients Receiving Targeted Therapy

Table 2

Comparison of patients’ clinicopathological features between the different NLR groups.

Indicators	Low-NLR group (n = 64)	High-NLR group (n = 19)	χ^2/t
Gender			0.0353	0.8509
Male	55 (85.9)	16 (84.2)
Female	9 (14.1)	3 (15.8)
Age			1.8671	0.1719
≤56	29 (45.3)	12 (63.2)
>56	35 (54.7)	7 (36.8)
History of alcoholism			0.5969	0.4398
Yes	34 (53.1)	12 (63.2)
No	30 (46.9)	7 (36.8)
ECOG score			0.1031	0.7481
0-1	33 (51.6)	9 (47.4)
≥2	31 (48.4)	10 (52.6)
Child–Pugh classification			0.1031	0.7481
A	33 (51.6)	9 (47.4)
B	31 (48.4)	10 (52.6)
BCLC stage			0.0014	0.9698
B	30 (46.9)	9 (47.4)
C	34 (53.1)	10 (52.6)
Maximum tumor diameter			0.9290	0.3351
≤5 cm	35 (54.7)	8 (42.1)
>5 cm	29 (45.3)	11 (57.9)
Number of lesions			0.2382	0.6255
Single	23 (35.9)	8 (42.1)
Multiple	41 (64.1)	11 (57.9)
Surgery			2.2101	0.1371
Yes	28 (43.8)	12 (63.2)
No	36 (56.2)	7 (36.8)

Note. PNI, prognostic nutritional index; NLR, neutrophil/lymphocyte ratio; ECOG, Eastern Cooperative Oncology Group; BCLC, Barcelona clinic liver cancer. Bold text: statistically significant.